Arvinas Inc. (NASDAQ: ARVN) stock closed at 61.34 per share at the end of the most recent trading day (a 1.47% change compared to the prior day closing price) with a volume of 358.38K shares and market capitalization of 3.00B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 133 people. Arvinas Inc. CEO is John Houston.

The one-year performance of Arvinas Inc. stock is 36.91%, while year-to-date (YTD) performance is -27.78%. ARVN stock has a five-year performance of %. Its 52-week range is between 19.68 and 92.77, which gives ARVN stock a 52-week price range ratio of 57.00%

Arvinas Inc. currently has a PE ratio of -21.40, a price-to-book (PB) ratio of 4.90, a price-to-sale (PS) ratio of 189.85, a price to cashflow ratio of 25.60, a PEG ratio of 2.32, a ROA of -23.42%, a ROC of -59.20% and a ROE of -27.47%. The company’s profit margin is -%, its EBITDA margin is -389.40%, and its revenue ttm is $15.56 Million , which makes it $0.32 revenue per share.

Of the last four earnings reports from Arvinas Inc., there were 1 positive earnings surprise and 3 negative earnings surprise. The company has EPS estimate of $-0.77 for the next earnings report. Arvinas Inc.’s next earnings report date is 27th Apr 2021.

The consensus rating of Wall Street analysts for Arvinas Inc. is Strong Buy (1.22), with a target price of $99.63, which is +62.42% compared to the current price. The earnings rating for Arvinas Inc. stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Arvinas Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Arvinas Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 16.88, ATR14 : 5.40, CCI20 : -87.72, Chaikin Money Flow : -0.14, MACD : -3.35, Money Flow Index : 40.78, ROC : -2.36, RSI : 41.01, STOCH (14,3) : 36.26, STOCH RSI : 0.44, UO : 45.19, Williams %R : -63.74), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Arvinas Inc. in the last 12-months were: Edward Kennedy (Buy at a value of $199 909), Ian Taylor (Option Excercise at a value of $103 296), John Houston (Option Excercise at a value of $728 960), John Houston (Sold 44 000 shares of value $3 466 601 ), Liam Ratcliffe (Buy at a value of $9 999 990), Liam Ratcliffe (Option Excercise at a value of $286 780), Ronald Peck (Option Excercise at a value of $531 600), Ronald Peck (Sold 21 256 shares of value $1 581 482 ), Sean A. Cassidy (Option Excercise at a value of $755 440), Sean A. Cassidy (Sold 51 959 shares of value $3 892 108 ), Timothy M. Shannon (Buy at a value of $193 800), Timothy M. Shannon (Option Excercise at a value of $570 163)